- Home
- UFI vs WHWK Comparison
UFI vs WHWK Comparison
Compare UFI & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- WHWK
- Stock Information
- Founded
- UFI 1969
- WHWK 2007
- Country
- UFI United States
- WHWK United States
- Employees
- UFI N/A
- WHWK N/A
- Industry
- UFI Textiles
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- WHWK Health Care
- Exchange
- UFI Nasdaq
- WHWK Nasdaq
- Market Cap
- UFI 84.6M
- WHWK 95.2M
- IPO Year
- UFI N/A
- WHWK N/A
- Fundamental
- Price
- UFI $4.39
- WHWK $2.43
- Analyst Decision
- UFI
- WHWK
- Analyst Count
- UFI 0
- WHWK 0
- Target Price
- UFI N/A
- WHWK N/A
- AVG Volume (30 Days)
- UFI 50.5K
- WHWK 5.1M
- Earning Date
- UFI 10-29-2025
- WHWK 11-15-2025
- Dividend Yield
- UFI N/A
- WHWK N/A
- EPS Growth
- UFI N/A
- WHWK N/A
- EPS
- UFI N/A
- WHWK N/A
- Revenue
- UFI $571,344,000.00
- WHWK $21,596,000.00
- Revenue This Year
- UFI $9.98
- WHWK N/A
- Revenue Next Year
- UFI $5.75
- WHWK N/A
- P/E Ratio
- UFI N/A
- WHWK N/A
- Revenue Growth
- UFI N/A
- WHWK N/A
- 52 Week Low
- UFI $4.25
- WHWK $1.39
- 52 Week High
- UFI $7.15
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- UFI 39.89
- WHWK 57.09
- Support Level
- UFI $4.32
- WHWK $2.19
- Resistance Level
- UFI $4.45
- WHWK $2.72
- Average True Range (ATR)
- UFI 0.15
- WHWK 0.33
- MACD
- UFI -0.03
- WHWK 0.02
- Stochastic Oscillator
- UFI 19.15
- WHWK 29.21
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.